IRadimed Corporation

IRMDNASDAQHealthcare● Active

$94.39

+$1.32(+1.42%)

Market Cap$1.2B

P/E Ratio—

52W High$107.9

52W Low$55.109

Avg Volume109K

Open$93.79

Beta0.92

Overview

IRadimed Corporation (IRMD) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · IRMD · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

131

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

IRadimed Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

IRMD insider buying and selling by quarter

IRMD insider selling · IRMD insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

483K241K0

2023 Q4

2024 Q2

2024 Q4

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · IRMD ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

IRMD executive sell shares · IRMD board member insider trading · IRMD insider trading SEC filing

Showing 92 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jun 4, 2026	Scharen-Guivel Hilda Frederique Director	Sale	1,766	$95.00	$168K	6,832	Form 4
Jun 4, 2026	Scharen-Guivel Hilda Frederique Director	Sale	1,234	$95.00	$117K	5,598	Form 4
Jun 1, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	400	$88.68	$35K	2,164,600	Form 4
Jun 1, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	775	$89.79	$70K	2,163,825	Form 4
Jun 1, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	401	$91.08	$37K	2,163,424	Form 4
Jun 1, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	924	$91.91	$85K	2,162,500	Form 4
May 26, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	3,111	$91.81	$286K	2,169,389	Form 4
May 26, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,889	$92.93	$176K	2,167,500	Form 4
May 27, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	2,167	$91.85	$199K	2,165,333	Form 4
May 27, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	333	$92.61	$31K	2,165,000	Form 4
May 18, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	298	$85.95	$26K	2,179,702	Form 4
May 18, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	3,451	$87.35	$301K	2,176,251	Form 4
May 18, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,251	$88.34	$111K	2,175,000	Form 4
May 19, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	653	$87.13	$57K	2,174,347	Form 4
May 19, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,841	$88.14	$162K	2,172,506	Form 4
May 19, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	6	$88.65	$532	2,172,500	Form 4
May 11, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,773	$84.08	$149K	2,185,727	Form 4
May 11, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,001	$84.94	$85K	2,184,726	Form 4
May 11, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	315	$85.90	$27K	2,184,411	Form 4
May 12, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	3,307	$83.70	$277K	2,181,104	Form 4
May 12, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,104	$84.59	$93K	2,180,000	Form 4
May 4, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	2,447	$85.32	$209K	2,192,553	Form 4
May 4, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	1,103	$86.26	$95K	2,191,450	Form 4
May 4, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	200	$87.05	$17K	2,191,250	Form 4
May 5, 2026	Susi Roger E. CEO, President, Chairman · Director	Sale	600	$83.78	$50K	2,190,650	Form 4

Scharen-Guivel Hilda Frederique

Director

Sale

Date

Jun 4

1,766

Price

$95.00

Value

$168K

View Form 4 on SEC.gov

Scharen-Guivel Hilda Frederique

Director

Sale

Date

Jun 4

1,234

Price

$95.00

Value

$117K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

Jun 1

400

Price

$88.68

Value

$35K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

Jun 1

775

Price

$89.79

Value

$70K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

Jun 1

401

Price

$91.08

Value

$37K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

Jun 1

924

Price

$91.91

Value

$85K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 26

3,111

Price

$91.81

Value

$286K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 26

1,889

Price

$92.93

Value

$176K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 27

2,167

Price

$91.85

Value

$199K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 27

333

Price

$92.61

Value

$31K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 18

298

Price

$85.95

Value

$26K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 18

3,451

Price

$87.35

Value

$301K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 18

1,251

Price

$88.34

Value

$111K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 19

653

Price

$87.13

Value

$57K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 19

1,841

Price

$88.14

Value

$162K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 19

Price

$88.65

Value

$532

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 11

1,773

Price

$84.08

Value

$149K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 11

1,001

Price

$84.94

Value

$85K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 11

315

Price

$85.90

Value

$27K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 12

3,307

Price

$83.70

Value

$277K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 12

1,104

Price

$84.59

Value

$93K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 4

2,447

Price

$85.32

Value

$209K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 4

1,103

Price

$86.26

Value

$95K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 4

200

Price

$87.05

Value

$17K

View Form 4 on SEC.gov

Susi Roger E.

CEO, President, Chairman · Director

Sale

Date

May 5

600

Price

$83.78

Value

$50K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About IRMD insider trading

IRMD insider trades

IRadimed Corporation (IRMD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Susi Roger E. (CEO, President, Chairman · Director), Scharen-Guivel Hilda Frederique (Director), GLENN JOHN (CHIEF FINANCIAL OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. IRMD insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For IRadimed Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

IRMD insider trading · 5 questions

The insiders of IRadimed Corporation (IRMD) include executives and directors such as Susi Roger E. (CEO, President, Chairman · Director), Scharen-Guivel Hilda Frederique (Director), GLENN JOHN (CHIEF FINANCIAL OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

IRMD board member insider tradingwho are IRMD insidersIRMD insider rosterIRadimed Corporation executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026